Skip to main content
. Author manuscript; available in PMC: 2019 Feb 22.
Published in final edited form as: Chem Biol Drug Des. 2011 Dec 22;79(2):157–165. doi: 10.1111/j.1747-0285.2011.01270.x

Table 3.

Antiviral potencies in cells infected with HIV-1 containing wild-type (WT) or mutant integrase enzymes.a

No. CC50 (μM) EC50 (μM, WT) Mutantsb
G140S/Q148H Y143R N155H
1 >100 0.004 ± 0.002 475x 41x 38x
2 >100 0.017 ± 0.004 5x 0.4x 1x
3 5.4 ± 1.3 1.7 ± 0.5 5x 1x 3x
5e 392 ± 66 9.2 ± 1.9 2x 2x 3x
a

Data was obtained as described in the Experimental Section.

b

Fold-loss of potency relative to virus containing WT enzyme.